Concomitant amplification or copy number gain of two genes is a common phenomenon in cancers, such as MYCN and DDX1 in neuroblastoma, ERBB2/HER2 and TOPOIIα in prostate cancer [27–29]. Here, ERBB2 is linked to prostate carcinoma.